This is the second part of our series on catheter-based development, following the journey from early design through preclinical evaluation.
If you missed the first part, you can read it here!
With a functional and tested system in place, the focus shifts toward ensuring that the device can be consistently manufactured, safely delivered, and supported through clinical and regulatory pathways.
Validating the system beyond performance
At this stage, development extends beyond device functionality into the broader system required for safe and reliable use.
MDS supported the validation of sterilization processes to ensure effective bioburden removal without affecting device performance. Packaging solutions were developed and tested to maintain sterility and integrity throughout storage and transport. In parallel, biocompatibility testing was carried out to confirm the suitability of materials for clinical use.
Together, these activities form a critical bridge between development and clinical application.
Ensuring consistency in production and delivery
Process validation and production planning were developed in parallel with these activities.
MDS contributed to defining and validating manufacturing processes, establishing controlled production methods, and supporting batch release procedures. The objective was not only to meet regulatory expectations, but to ensure repeatability and consistency across production.
In addition, the broader logistics and production chain were considered as part of the system. Ensuring that devices could be reliably produced, handled, and delivered to clinical environments was a key part of overall readiness.
Supporting the transition to clinical use
With validated processes in place, the project progressed into human clinical studies.
MDS was involved in designing clinical study protocols, supporting regulatory approvals for human use, and participating in clinical activities. The studies were conducted in accordance with Good Clinical Practice (GCP), ensuring data quality, patient safety, and regulatory compliance throughout.
Feedback from clinical use was actively collected, providing valuable insight into device performance, usability, and procedural integration.
Building the regulatory and quality framework
Alongside technical and clinical work, the regulatory and quality foundation was developed continuously.
MDS supported the construction of technical documentation and the development of the quality management system, ensuring alignment with both EU and FDA expectations. Interactions with regulatory authorities were part of this process, supporting progress toward CE marking and broader market access.
Rather than being treated as a final step, regulatory readiness was built in parallel with development, strengthening overall project coherence.
From development to market access
One of the defining aspects of this project has been continuity across all phases.
From early design and material selection to supplier validation, preclinical and clinical activities, and regulatory preparation, development has been approached as a connected process. This reduces fragmentation and supports a more efficient and predictable path toward market access.
Supporting catheter-based innovation
Catheter-based solutions continue to play an increasingly important role in minimally invasive healthcare.
Their success depends not only on the implant itself, but on how effectively the entire system is developed, validated, and integrated into clinical use.
At MDS, this system-level perspective is central to how we support our clients across the full product lifecycle.
Get in touch
If you are developing catheter-based or minimally invasive medical devices, MDS works alongside your team across development, validation, and market access, with a practical and integrated approach. To learn more, you can contact us at Kristian@mdsdenmark.dk or via Book a Meeting.